|
|
||||||||
1Institute for Hygiene and Infectious Diseases of Animals, Justus-Liebig-University, D-35392 Giessen, Germany 2,3Division of Microbiology2 and Division of Immunology & Pathology3, Institute for Animal Health, Compton Laboratory, Compton, Berkshire RG20 7NN, UK
Correspondence Christian Menge christian.menge{at}vetmed.uni-giessen.de
Received November 6, 2003
Accepted January 28, 2004
Ruminants are a major reservoir of enterohaemorrhagic Escherichia coli (EHEC), which cause acute gastroenteritis in humans with potentially life-threatening sequelae. The mechanisms underlying EHEC persistence in ruminant hosts are poorly understood. EHEC produce several cytotoxins that inhibit the proliferation of bovine lymphocytes in vitro and influence EHEC persistence in calves, suggesting that bacterial suppression of mucosal inflammation may be important in vivo. In order to address this hypothesis, intraepithelial lymphocytes (IEL) obtained from ligated intestinal loops of five 914 day old calves were characterized 12 h after inoculation with E. coli strains. Loops were inoculated with an EHEC O103 : H2 strain, an isogenic
stx1 mutant incapable of producing Shiga toxin 1 (Stx1) and a porcine non-pathogenic E. coli strain. The IEL mainly comprised activated CD2+ CD3+ CD6+ CD8
+ T cells and resembled IEL obtained from the intestinal mucosa of orally challenged calves. Forty per cent of all IEL were potentially sensitive to Stx1 in that they expressed the receptor for Stx1. Nevertheless, analysis of IEL from inoculated loops failed to detect a significant effect of the different E. coli strains on proliferative capacity, natural killer cell activity or the cytokine mRNA profile. However, the EHEC wild-type strain reduced the percentage of CD8
+ T cells in the ileal mucosa compared with loops inoculated with the
stx1 mutant. This shift in IEL composition was not associated with inhibition of IEL proliferation in situ, since the majority of the IEL from all loops were in the G0/G1 phase of the cell cycle. These studies indicate that the ligated ileal loop model will be a useful tool to dissect the mechanisms underlying suppression of mucosal inflammation by EHEC in the reservoir host.
| INTRODUCTION |
|---|
|
|
|---|
B and the synthesis of proinflammatory cytokines in vitro (Hauf & Chakraborty, 2003). EHEC also produce several cytotoxins including Shiga toxin(s) (Stx1 and/or Stx2) and lymphostatin, the latter of which influences intestinal colonization of calves (Stevens et al., 2002c). Both Stx1 and lymphostatin inhibit the proliferation of bovine peripheral blood lymphocytes in vitro (Menge et al., 1999; Ferens & Hovde, 2000; Stevens et al., 2002c). In addition, lymphostatin can block the proliferation of human and murine intestinal lymphocytes in vitro (Klapproth et al., 1996; Malstrom & James, 1998). Bovine intestinal intraepithelial lymphocytes (IEL) express functional Stx1 receptors, and Stx1 blocks proliferation and affects the expression of cytokines in these cells (Stamm et al., 2002; Menge et al., 2004). Studies are required to confirm that such immunomodulatory strategies are relevant in the complex environment of the intestine in the target animal species (Smith et al., 2002; Hein & Griebel, 2003).
Intestinal loop models have been used in ruminants to study enteropathogenic responses to bacterial pathogens. EHEC elicit enteropathogenic responses in such loops and adhere to the epithelium, forming attaching and effacing lesions (Sandhu & Gyles, 2002; Stevens et al., 2002a). Recently, Gerdts et al. (2001) established that intestinal loops are a valuable model for the analysis of mucosal immune responses. We therefore assessed the phenotype and function of IEL in a bovine ligated intestinal loop model of EHEC infection in order to identify bacterial and host factors that modulate inflammatory responses during EHEC infection of cattle.
| METHODS |
|---|
|
|
|---|
stx1+; Mariani-Kurkdjian et al., 1993), an isogenic PMK5
stx1 mutant (Stevens et al., 2002a) and NADC5738 (Dean-Nystrom et al., 1997), which is a nalidixic acid-resistant derivative of the porcine non-pathogenic E. coli O43 : H28 strain 123 (Moon et al., 1968). Bacterial strains were cultured in brain heart infusion (BHI) broth for 18 h at 37 °C and the optical density at 600 nm of inocula was adjusted to within 0.1 units. Viable bacteria in adjusted inocula were enumerated by plating serial tenfold dilutions onto MacConkey agar. Recombinant B-subunit of Stx1 (rStxB1) was purified by anion-exchange chromatography as described by Stamm et al. (2002). Anti-StxB1 was purified by Protein A/G (Schleicher & Schuell) affinity chromatography from the mouse hybridoma cell line 13C4 (Strockbine et al., 1985).
Animals.
All animal experiments were performed in accordance with the Animals (Scientific Procedures) Act 1986 (UK) and were approved by the local Ethical Review Committee. Conventional Friesian bull calves were fed on milk replacer twice daily with free access to water and were screened for excretion of EHEC or Salmonella by enrichment on sorbitol MacConkey agar containing tellurite and cefixime or Brilliant green agar, respectively. Calves were observed twice daily for 7 days prior to surgery and animals with diarrhoea or excreting EHEC were excluded from the analysis.
Oral inoculation of calves.
Calves aged 2022 days were challenged orally with 3.97 x 1010 c.f.u. of strain PMK5 or 4.63 x 1010 c.f.u. of NADC5738 in antacid as described by Stevens et al. (2002c).
Ligated intestinal loop assay.
The bovine ligated ileal loop assay has been described previously (Stevens et al., 2002a). Briefly, calves were anaesthetized for the duration of the experiment (approx. 14 h) with pentobarbitone sodium [Sagatal, 0.44 ml (kg body weight)1] and the mid-ileum was flushed with intestinal wash solution (5.61 mg NaCl; 0.11 mg KCl; 1.09 mg KH2PO4; 0.16 mg Na2HPO4; 7.04 mg trisodium citrate and 5 mg N-acetyl cysteine ml1). Calves were maintained at 38.539.5 °C by the use of heated mats. Four mid-ileal loops per animal approx. 40 cm in length with 10 cm spacers were ligated with surgical silk and inoculated with 40 ml bacterial culture (PMK5, 4.58 ± 0.70 x 1010 c.f.u. per loop; PMK5
stx 4.02 ± 0.67 x 1010 c.f.u. per loop; NADC5738 5.84 ± 1.37 x 1010 c.f.u. per loop) or sterile medium (BHI) as a negative control. Each strain was tested once per animal and the experiment was repeated in a total of five calves.
Isolation of IEL.
Twelve hours after loop inoculation and immediately after the administration of an overdose of anaesthetic, the infected mucosa was collected into ice-cold PBS. IEL (approx. 2 x 108 cells per loop) were isolated from the recovered mucosa after treatment with 1,4-DTT (1 mM in PBS, 1525 min at 37 °C with shaking) by incubation with an EDTA solution containing an inhibitory concentration of antibiotics (2 mM EDTA in PBS, 100 U penicillin ml1, 100 µg streptomycin ml1, 2.5 µg gentamicin ml1; 20 min at 37 °C with shaking) and mechanical detachment (vortexing). The cells were resuspended in Percoll at a density of 1.05 g ml1, layered onto Percoll at a density of 1.0816 g ml1 and separated by centrifugation at 677 g for 20 min (Menge et al., 2004).
Immunophenotyping.
Freshly isolated IEL were transferred to microtitre plates for the staining of cell differentiation and activation markers for flow cytometry as described (Menge et al., 1999; Stamm et al., 2002). IEL were incubated with antibodies/rStxB1 in the dark for 20 min. Detected antigens and the respective antibodies used were: CD2 (IL-A 43), CD4 (IL-A 11), CD6 (IL-A 57), CD8
(IL-A 105), CD21 (IL-A 65), a macrophage/granulocyte differentiation antigen (IL-A 24), WC1 (
T cells, IL-A 29), CD25 (IL-A 111), CD71 (IL-A 77), MHC-II (J11) (all antibodies provided by J. Naessens, International Livestock Research Institute, Nairobi, Kenya), CD3 (MM1A), CD8ß (BAT82A), ACT-2 (CACT26A), TcR1-N7 (CACTB81A), TcR1-N6 (CACTB6A), TcR1-N12 (CACT61A) (all antibodies purchased from VMRD, Pullman, WA, USA) and CD77 (clone 38.13; Beckman Coulter). Binding of rStxB1 (30 µg ml1) was detected with anti-StxB1 (45 µg ml1). Visualization was carried out with FITC-labelled secondary antibodies. Cells were analysed with a FACSCalibur flow cytometer acquiring 5000 events for each sample.
Natural killer (NK) cell activity assay.
A bovine lymphoma cell line (BL-3, ECACC 86962401) was used as target cells. Target cells (T) prestained with 3,3'-dioctadecyloxacarbocyanine perchlorate (DiO) were added to IEL as effector cells (E) in different ratios (E : T 100 : 1, 33 : 1 and 11 : 1) and incubated for 18 h at 37 °C. Affected target cells were detected by flow cytometry according to their altered morphology (i.e. increase in granularity).
Cell cycle determination/DNA analysis.
IEL were fixed with ethanol (70 %, v/v) immediately after isolation. DNA was stained with propidium iodide (PI) after RNase A digestion and proportions of cells in the different cell cycle compartments were assessed by flow cytometry analysis according to their PI signal (Noguchi, 1991).
Lymphocyte stimulation-proliferation assay.
To examine proliferative capacity after mitogen stimulation, IEL were cultured for 3 days at 37 °C in medium supplemented with rhuIL2 (200 U ml1) and either phytohaemagglutinin (PHA-P, 2.5 µg ml1) or phorbol-12-myristate-13-acetate (PMA, 5 ng ml1) and ionomycin (500 ng ml1). The proportion of viable cells transformed to blast cells and non-transformed non-blast cells relative to an unstimulated control was determined by flow cytometry according to the light scatter characteristics of cells with PI exclusion of dead cells.
Cytokine mRNA profile.
After incubation of IEL in medium supplemented with 2.5 µg PHA ml1 and 200 U rhuIL2 ml1 for 30 min, RNA was isolated from cells using an RNeasy MiniKit (Qiagen), treated with DNase I and reverse transcribed to cDNA. Cytokine-specific PCRs for il2, il4, il8, il10 and ifn-
were carried out following standard procedures. Previously published cytokine primers (Gohin et al., 1997; Morsey et al., 1996) were used with minor modifications: il2 (sense, 5'-TCTTGCATTGCACTAACTCT-3'; antisense, 5'-GCT TTGACAAAAGGTAATCC-3'), il4 (sense, 5'-GCCACTTCGTCCAT GGACAC-3'; antisense, 5'-TCCCAAGAGGTCTCTCAGCG-3'), il8 (sense, 5'-GCAGTTCTGTCAAGAATGAG-3'; antisense, 5'-GGATCT TGCTTCTCAGCTC-3'), il10 (sense, 5'-TGTTGCCTGGTCTTCCTG-3'; antisense, 5'-TCTCTTCACCTGCTCCAC-3'), ifn-
(sense, 5'-GCT TTACTGCTCTGTGTGCT-3'; antisense, 5'-GACTTCTCTTCCGCTT TCTG-3') and gapdh (sense, 5'-ATCACTGCCACCCAG-3'; antisense, 5'-CATGCCAGTGAGCTT-3'). The GAPDH gene was used as a control for constitutive gene expression. The amplification reaction was carried out for a total of 35 cycles as follows: 94 °C for 30 s, 55 °C for 30 s and 72 °C for 90 s, with a precycle of 94 °C for 15 s and final extension at 72 °C for 5 min. Cytokine signals were evaluated after gel electrophoresis from densitometry measurements and values were normalized to a GAPDH signal.
Statistical analysis.
Data were analysed statistically using BMDP (Statistical Software) and SigmaStat software (SPSS). P values were calculated by StudentNewmanKeuls test and one-way repeated measures ANOVA and considered significant when P
0.05.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
|
IEL composition differed little between calves that were inoculated with PMK5 or NADC5738. It is noteworthy, however, that the portion of Gb3/CD77+ and rStxB1 binding ileal IEL was reduced in the calf that received the EHEC strain. In addition, the portion of ileal and colonic intraepithelial T cells expressing CD8
and CD8ß was markedly lower in this animal. In turn, other T cell populations including CD3+, CD4+, CD6+ and N12+ 
T cells were enhanced at colonic sites in the PMK5-inoculated animal.
The majority of IEL from both calves were in the G0/G1 phase of the cell cycle and mitogen stimulation did not result in proliferative responses in comparison to unstimulated cells (data not shown). IEL are known to respond only poorly to mitogens and nominal antigens in vitro, despite their activated appearance and phenotype (Mowat & Viney, 1997). Nevertheless, isolated IEL were still functionally active in that they exerted an NK cell activity towards a homologous cell line, and inoculation with EHEC did not influence this activity (Fig. 2). Detection of this activity required high effector to target cell ratios and was slightly higher in colonic IEL preparations.
|
Immunophenotype of IEL exposed to EHEC in situ in a ligated intestinal loop model of EHEC infection
Mid-ileal loops were constructed in a total of five conventional calves aged 914 days and inoculated with either PMK5, PMK5
stx1, NADC5738 or sterile medium as a control. Since it is known that Stx1 inhibits the activity of bovine lymphocytes in vitro (Stamm et al., 2002; Menge et al., 2003), the stx1 mutant was included to determine whether mucosal immunomodulatory effects due to Stx1 could be detected in vivo. Viable IEL could be isolated after 12 h from all mid-ileal loops inoculated with the different E. coli strains. Immunophenotyping of the IEL revealed their composition was very similar to IEL derived from ileal mucosa from orally inoculated calves (Figs 1 and 3). IEL from mid-ileal loops comprised mainly activated CD2+ CD3+ CD6+ ACT-2+ T cells, with approximately 60 % CD8
+, 50 % CD8ß+, 10 % CD4+ and 25 % 
T cells, suggesting that the integrity of the mucosal layer had been maintained (Fig. 3). Forty per cent of all IEL expressed the Stx receptor Gb3/CD77 and were capable of binding rStxB1. Few changes in the phenotype of the recovered IEL could be detected between loops inoculated with EHEC and control loops filled with NADC5738 or sterile medium (Fig. 3). StudentNewmanKeuls test following one-way repeated measures ANOVA revealed that the wild-type Stx1-producing EHEC strain PMK5 significantly reduced the percentage of CD8
+ T cells by 5.52 ± 3.4 % (P
0.05) compared with loops inoculated with the PMK5
stx1 mutant or the non-pathogenic E. coli strain. A slight decrease in the portion of CD8ß+, CD6+ and CD2+ IEL in PMK5-inoculated loops could also be detected, although differences reached significance only in the latter case. These findings reflect the differential expression of Stx receptors by several IEL subpopulations: in the ileum of adult cattle, the majority of Gb3/CD77+ IEL are activated CD3+ CD6+ CD8
+ T cells, whereas CD4+ T cells and B cells express much less Gb3/CD77 (Menge et al., 2004). Inoculation of the loops with PMK5 did not influence the number of Gb3/CD77+ IEL, but slightly reduced the number of rStxB1-binding cells. In vitro, Stx1 affects bovine peripheral lymphocytes early in the activation process (Stamm et al., 2002) when the cells express an isoform of Gb3/CD77 with a high affinity for rStxB1 that is not recognized by anti-CD77 (Menge et al., 2003). Stx1 thus probably eliminated from the loop mucosa only those IEL that were not recognized as Gb3/CD77+ cells in either loop.
|
The finding that Stx1 specifically depletes a subset of bovine lymphocytes in the complex environment of the intestine is a significant step forward in our understanding of the modulation of mucosal immune responses by EHEC. To the best of our knowledge, the present study provides the first direct evidence that Stx1 acts as a virulence factor in cattle. Suppression of immune function in the gut through depletion of CD8
and probably CD8ß T cells may facilitate intestinal colonization; however, there is presently a paucity of published data to support this role (reviewed by Smith et al., 2002). Stx-positive E. coli O157 : H7 have been reported to colonize the intestines of weaned calves more effectively than Stx-negative strains (Dean-Nystrom et al., 1998); however, the strains used were not isogenic and the differences could be due to traits other than Stx production.
Cell cycle progression and proliferation of IEL exposed to EHEC in situ
Between 88.65 ± 2.11 and 90.14 ± 2.43 % of IEL (mean ± SD of triplicate determinations of five animals) from the loops were in the G0/G1 phase of the cell cycle. The response to mitogen stimulation was low and did not differ between IEL preparations obtained from the different loops (data not shown). The effect of Stx1 on IEL composition is therefore not a consequence of inhibition of cell proliferation in situ. We recently reported that the ability of Stx1 to block the proliferation of bovine peripheral CD8
+ Gb3/CD77+ T lymphocytes is due to direct toxic action and is not mediated via perturbation of autocrine cytokine release within the lymphocyte cultures (Menge et al., 2003). Although previous reports failed to detect a cytotoxic activity of Stx1 for bovine lymphocytes (Menge et al., 1999; Ferens & Hovde, 2000), Stx1 was recognized as a potent cytotoxin in other cellular systems (Sandvig, 2001). Therefore, we cannot exclude the possibility that Stx1 eliminated sensitive IEL from the mucosa of PMK5-inoculated loops.
The IEL composition in loops inoculated with a non-pathogenic E. coli strain did not significantly differ from loops inoculated with PMK5
stx1. The latter strain, but not NADC5738, contains the gene for lymphostatin (lifA), which influences colonization of the bovine intestine by EHEC serotypes O5 and O111 (Stevens et al., 2002c). Lymphostatin represents another EHEC factor that blocks lymphocyte proliferation in vitro (Klapproth et al., 2000; Stevens et al., 2002c); however, no lymphostatin-like effects on IEL phenotype and function were detected in the present study.
Cytokine mRNA synthesis and NK cell activity of IEL exposed to EHEC in situ
Several EHEC virulence factors inhibit the synthesis of cytokines by mitogen-activated mucosal lymphocytes in vitro, including lymphostatin (Klapproth et al., 1996; Malstrom & James, 1998) and Stx1 (Menge et al., 2004). We therefore assessed the effect of exposure of bovine IEL in situ to different E. coli strains on the mitogen-activated transcription of il2, il4, il8, il10 and ifn-
. Upon mitogenic stimulation of recovered IEL for 30 min in vitro, suitable amounts of intact RNA could be recovered and subjected to semi-quantitative RT-PCR. IEL preparations obtained from different donor animals varied in their cytokine gene expression (Fig. 4). While inoculation of loops with PMK5 increased the IL2 signal in four out of five animals in comparison with loops inoculated with PMK5
stx1, the expression of IFN-
was reduced to different extents in all five animals. The amounts of IL4-, IL8- and IL10-specific mRNA (Fig. 4; data for IL10 not shown) varied inconsistently between the loops and the animals.
|
IEL preparations from all the inoculated loops exhibited a higher NK cell activity than ileal IEL obtained from the orally challenged calves, but no significant differences between IEL exposed to the different E. coli strains were detectable (Fig. 5).
|
Gut-associated lymphoid tissues trap antigen at sites of infection and present it to migratory lymphocytes, leading ultimately to the development of antigen-specific mucosal immunity. It may be speculated that EHEC cytotoxins suppress these events once the bacteria are intimately associated with the epithelium in order to prevent clearance. Accordingly, Stx1 had been shown to hinder peripheral lymphocyte functions in vitro (Menge et al., 1999), and presumably in vivo (Hoffman et al., 1997). However, the fact that humoral and mucosal immune responses against EHEC antigens can be readily detected after experimental and natural infection of cattle (Johnson et al., 1996; Pirro et al., 1995) argues against a general immune suppression. Moreover, IEL differ strikingly functionally from peripheral lymphocytes (Mowat & Viney, 1997). IEL do exhibit cytotoxicity against virus-infected cells (Müller et al., 2000), but, in the first place, these cells form an indispensable part of the mucosal regulatory network that maintains intestinal homeostasis (Fiocchi, 1997). By releasing soluble factors, IEL control the migration and activation of inflammatory cells as well as a number of epithelial cell functions including proliferation (Mowat & Viney, 1997). It is thus tempting to assume that, by modulating IEL functions, EHEC prevent the onset of mucosal inflammatory responses that would otherwise follow bacterial adhesion to the mucosal surface (Zhou et al., 2003). In addition to directly affecting epithelial cell functions (Hoey et al., 2002, 2003), EHEC would be able, by this mechanism, to influence epithelial cell turnover indirectly, which correlates with the duration of EHEC shedding in calves (Magnuson et al., 2000). Using Stx1 as a prototype for EHEC factors with immunomodulatory activity, the bovine ligated intestinal loop model proved suitable to dissect the effect of bacterial factors on different aspects of the intestinal immune response during EHEC O103 : H2 infections in this reservoir host.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| REFERENCES |
|---|
|
|
|---|
B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli. J Immunol 170, 20742082.
, and interferon-
. Exp Biol Med 228, 377386.This article has been cited by other articles:
![]() |
I. Aktan, R. M. La Ragione, and M. J. Woodward Colonization, Persistence, and Tissue Tropism of Escherichia coli O26 in Conventionally Reared Weaned Lambs Appl. Envir. Microbiol., February 1, 2007; 73(3): 691 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Hoffman, C. Menge, T. A. Casey, W. Laegreid, B. T. Bosworth, and E. A. Dean-Nystrom Bovine Immune Response to Shiga-Toxigenic Escherichia coli O157:H7 Clin. Vaccine Immunol., December 1, 2006; 13(12): 1322 - 1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dziva, P. M. van Diemen, M. P. Stevens, A. J. Smith, and T. S. Wallis Identification of Escherichia coli O157 : H7 genes influencing colonization of the bovine gastrointestinal tract using signature-tagged mutagenesis Microbiology, November 1, 2004; 150(11): 3631 - 3645. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Stevens, A. J. Roe, I. Vlisidou, P. M. van Diemen, R. M. La Ragione, A. Best, M. J. Woodward, D. L. Gally, and T. S. Wallis Mutation of toxB and a Truncated Version of the efa-1 Gene in Escherichia coli O157:H7 Influences the Expression and Secretion of Locus of Enterocyte Effacement-Encoded Proteins but not Intestinal Colonization in Calves or Sheep Infect. Immun., September 1, 2004; 72(9): 5402 - 5411. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |